Hinge Health, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Hinge Health, Inc. (HNGE) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $77.87 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-06
- Hinge Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$21.68M.
- Hinge Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was -$12.30M.
- Hinge Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was -$92.79M, a 242.51% decline from fiscal 2024.
- Hinge Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $65.11M.
- Hinge Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$65.41M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | $77.87M 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | -$21.68M 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | -$92.79M 10-K · filed 2026-03-03 | |||
| 2025-09-30 | -$39.44M 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | -$63.61M 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | -$12.30M 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | $65.11M 10-K · filed 2026-03-03 | |||
| 2024-09-30 | $32.22M 10-Q · filed 2025-11-07 | |||
| 2024-06-30 | $1.32M 10-Q · filed 2025-08-11 | |||
| 2023-12-31 | -$65.41M 10-K · filed 2026-03-03 |